logo dark logo light logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
mobile-logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
We are Company Builders

We are Company Builders

Identifying, incubating and growing future industry leaders in life sciences.

We are Industry Veterans

We are Industry Veterans

Capturing evolving healthcare trends and emerging cutting-edge innovations

We are Preferred Partners

We are Preferred Partners

Connecting companies with extensive network and resources globally and in China

  • Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306

    ...

    March 18, 2026
  • Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026

    ...

    March 11, 2026
  • Gilead Sciences to Acquire Arcellx to Maximize Long-term Potential of Anito-cel

    ...

    February 23, 2026
All news

899 Halei Road, Building B, 4/F, Pudong New Area, Shanghai 201203, P.R. China
Phone: +86 21 6163 2598 | Fax: +86 21 6163 2570 | Email: info@quancapital.com

© Quan Capital. All rights reserved. Website Development. 沪ICP备18031693号-1